Markets

Oracle Shares Slide 4.4% on Project Jupiter Force Majeure Notice

Oracle shares fell 4.4% after a force majeure notice on Project Jupiter raised delay risks. With $288B in lease commitments and negative free cash flow, investors question execution.

Daniel Marsh · · · 3 min read · 438 views
Oracle Shares Slide 4.4% on Project Jupiter Force Majeure Notice
Mentioned in this article
BE $265.04 -3.69% ORCL $138.42 -4.25% OWL $9.15 -4.69%

Oracle Corporation (NYSE: ORCL) experienced a sharp decline on Thursday, with shares trading at $138.15, down 4.4% by 12:05 p.m. EDT. The drop follows a Bloomberg report, cited by Reuters, indicating that Oracle sent a force majeure notice to the developer of Project Jupiter, a massive data center campus in New Mexico. The notice seeks payment protection if the project's scheduled 2028 opening is delayed.

Project Jupiter is a cornerstone of Oracle's ambitious artificial intelligence infrastructure expansion. The company's latest filing, dated August 31, disclosed an additional $288 billion in lease commitments, underscoring the scale of its long-term obligations. While one campus represents a fraction of this total, the notice signals a potential shift in how delay costs are allocated, raising questions about the resilience of Oracle's growth strategy.

Market Reaction and Trading Volume

The selloff was notably broader than a general technology downturn. Oracle's trading volume reached 37.1 million shares by midday, 1.23 times its 22-session average. In comparison, the S&P 500 dipped only 0.46%, indicating that Oracle-specific concerns drove the decline. Other stocks tied to the project, such as Blue Owl Capital (NYSE: OWL), also fell 4.22%, while Bloom Energy (NYSE: BE) dropped 6.33%.

Project Jupiter: Execution Risk

Oracle maintains that Project Jupiter remains on schedule. "We are fully committed to New Mexico and confident in our path forward," the company told CNBC. Blue Owl Capital, a financial partner, echoed this sentiment, stating that the notice does not alter the project's financial commitments. However, the dispute centers on a pending air permit for 2,275 methane-fueled cells generating 2.46 gigawatts. New Mexico's attorney general challenged the accelerated permitting process on September 3, citing curtailed discovery and due-process protections.

There is a counterpoint: the New Mexico Supreme Court lifted temporary stays on September 17, allowing air and water proceedings to resume. Yet, the court did not approve the underlying permits, leaving uncertainty. The next public test is the air-permit decision, with a statutory deadline of November 23.

Oracle's Financial Burden

Oracle's growth story is compelling but costly. In fiscal Q1 2027 (ended August 31), total revenue surged 30% year-over-year to $19.345 billion, with cloud infrastructure revenue more than doubling to $7.388 billion. Remaining performance obligations reached $664 billion, up 46% from a year ago. However, capital expenditures skyrocketed to $28.499 billion, a 235% increase, exceeding revenue by $9.15 billion. This pushed free cash flow to a negative $5.396 billion, compared to a negative $0.362 billion a year earlier.

The balance sheet carries significant leverage. As of August 31, Oracle reported $125.0 billion in senior notes and long-term borrowings, with an estimated fair value of $105.7 billion. The company also raised $19.9 billion through an at-the-market stock program last quarter, indicating a reliance on equity issuance to fund its expansion.

Analyst Views and Implications

Analyst recommendations vary widely. Recent calls include a Sell from Rothschild & Co Redburn with a $110 target, a Hold from Morgan Stanley at $210, and Buys from Phillip Securities ($225), Wells Fargo ($280), and Mizuho ($320). These targets, based on the $138.15 intraday price, imply returns ranging from -20.4% to +131.7%. Notably, all these calls predate Thursday's notice, suggesting that the market is now pricing in a higher probability of delay.

Oracle may be exercising prudent contract management, and it has not indicated any intent to abandon Project Jupiter. Blue Owl's statement supports continuity. However, the share reaction reflects investor anxiety over potential delays that could widen financing costs, defer cloud capacity, and test the value of its massive backlog.

As the air-permit process unfolds, investors will closely watch whether the new hearing schedule can meet the November deadline. A favorable outcome could restore confidence, but any slippage could exacerbate the financial strain and undermine Oracle's AI-driven growth narrative.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →